Status:
TERMINATED
OPTIMA-TBI Pilot Study
Lead Sponsor:
University of Michigan
Conditions:
Mild Traumatic Brain Injury
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This is a double-blind, randomized controlled trial comparing the effect of omega-3 fatty acid versus placebo on blood biomarkers of brain injury, inflammation and neurogenesis.
Detailed Description
Primary brain injury, the initial physical injury to brain tissue post-trauma, responds only to measures that prevent TBI from occurring in the first place. However, secondary brain injury, a complex ...
Eligibility Criteria
Inclusion
- Individuals presenting to the emergency department (ED) within 24 hours of injury, who meet the American Congress of Rehabilitation Medicine (ACRM)'s definition of having mild traumatic brain injury (mTBI) will be eligible
- The ACRM defines mTBI as a traumatically-induced physiological disruption of brain function as a consequence of the head being struck, striking an object, or undergoing an acceleration/deceleration movement without direct external head trauma and resulting in at least one of the following:
- any period of loss of consciousness (LOC)
- any loss of memory for events immediately before or after the injury
- any alteration in mental state at the time of the injury (eg, feeling dazed, disoriented, or confused)
- focal neurological deficit(s) that may or may not be transient
Exclusion
- GCS\<13 at any time during ED stay.
- Significant polytrauma including: bony fracture or solid organ injury
- Study medication cannot be administered within 24 hours of injury
- Patient cannot be relied on to complete follow-up (i.e. no reliable telephone number, substance dependence, homeless)
- Cannot communicate in English
- Take an anticoagulant (coumadin or a novel oral anticoagulant) daily
- Age less than 18 years or greater than 65 years
- Patients already taking fish oil supplements daily
- History of cognitive impairment
- Allergic to fish/fish oil
- Pregnant women (self-reported)
Key Trial Info
Start Date :
September 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03345550
Start Date
September 12 2017
End Date
July 27 2021
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109